Aparna Deora

Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.

Louise R. Howe, Kotha Subbaramaiah, Jay Patel et al. · PubMed · 2002 · 223 citations

Tumor Biology, Breast Oncology, Endocrine-related Cancer +14

Use of Toll-Like Receptor Assays To Detect and Identify Microbial Contaminants in Biological Products

Liyun Huang, James L. DuMontelle, Melissa D. Zolodz et al. · Journal of Clinical Microbiology · 2009 · 67 citations · Full text

The effect of preexisting anti-carrier immunity on subsequent responses to CRM₁₉₇or Qb-VLP conjugate vaccines

Michael J. McCluskie, Dana M. Evans, Ningli Zhang et al. · Immunopharmacology and Immunotoxicology · 2016 · 37 citations

Anti-IgE Qb-VLP Conjugate Vaccine Self-Adjuvants through Activation of TLR7

Bassel Akache, Risini D. Weeratna, Aparna Deora et al. · Vaccines · 2016 · 31 citations · Full text

Microbial Pathogens, Immunology, Immunodominance +19

Viral Protein U (Vpu)-Mediated Enhancement of Human Immunodeficiency Virus Type 1 Particle Release Depends on the Rate of Cellular Proliferation

Aparna Deora, Lee Ratner · Journal of Virology · 2001 · 30 citations · Full text